Development of Subtle Iron Deficiency During Vitamin E Treatment For Metabolic Dysfunction-Associated Steatotic Liver Disease.
- 2025-02-17
- Clinical Trial · n = 20
- Journal of dietary supplements 22(2)
- Maren C Podszun
- Ahmad Samer Alawad
- Shilpa Lingala
- Nevitt Morris
- Wen Chun A Huang
- Yaron Rotman
- PubMed: 39960325
- DOI: 10.1080/19390211.2025.2465414
- Moderate evidence
- Clinical
anemia to occur in 6 of the 11 (30% of study population) after 23 weeks (16-36)
- Effect
- Harmful
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 200 - 800 IU/d